Key result
Nicotine vaping products linked to cigarette cessation in ~63% of reviewed PATH analyses.
Why the study?
Controversy remains regarding whether nicotine vaping products are associated with cigarette cessation in observational research, and prior reviews have largely overlooked studies using the same data source.
Do nicotine vaping products improve cigarette cessation in adult smokers?
Do nicotine vaping products improve cigarette cessation in adult smokers?
Daily use of nicotine vaping products may support smoking cessation in adults, though findings vary based on study design and participant quit intentions.
NVP may aid cessation but should not change practice; leaves open causality pending dedicated RCTs.
INTRODUCTION: Controversy remains regarding whether nicotine vaping products (NVPs) are associated with cigarette cessation in observational research. Reviews have largely overlooked studies using the same data source. To address this gap, we conducted a narrative review to examine the heterogeneity in the reported association that used data from the same source, which may help to explain inconsistent findings. METHODS: We identified empirical studies through PubMed and Google searches that exclusively used the Population Assessment of Tobacco and Health (PATH) Study data to examine associations between NVP use and smoking cessation among adults. Adapting Arksey and O'Malley's approach, we extracted and summarized key study characteristics, including inclusion criteria, participant characteristics, study durations, definitions of NPV exposure and smoking outcomes, covariate adjustment, and analytic methods. We also conducted regression and regression tree analyses to examine how these characteristics were related to study findings. RESULTS: We identified 28 articles comprising 38 analyses of NVP use and cigarette cessation. Of these, 24 studies (63.2%) reported a positive association, concluding that NVP use predicted cessation. Substantial heterogeneity existed across study characteristics. Evidence suggests that daily NVP use may promote cessation, whereas studies restricted to participants with an intention to quit were less likely to observe cessation than those including participants regardless of quit intention. CONCLUSIONS: Researchers are advised against making broad claims based on any single PATH Study analysis of NVP use and smoking cessation. Rather, multiple studies using the same data source must be carefully examined in order to synthesize evidence and assess consistency of the findings. IMPLICATIONS: Whether NVPs help adult smokers quit remains controversial in observational research, partly due to heterogeneity in study characteristics across studies using the same data source. Our review of observational studies based exclusively on a single data source-an approach often overlooked-suggests that (1) daily NVP use may support smoking cessation, and (2) studies that restricted participants to those with an intention to quit were less likely to observe cessation than studies that included participants regardless of quit intention. These findings underscore the value of multiple analyses using the same data source to synthesize evidence and assess consistency.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) conducted a review in Smoking cessation. Nicotine vaping products (NVPs) was evaluated on Cigarette cessation. A narrative review of 38 analyses from the PATH Study found that 63.2% (24 studies) reported a positive association between nicotine vaping product use and cigarette cessation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: